These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 9055206

  • 1. Structure and bioactivity of recombinant human CTAP-III and NAP-2.
    Proudfoot AE, Peitsch MC, Power CA, Allet B, Mermod JJ, Bacon K, Wells TN.
    J Protein Chem; 1997 Jan; 16(1):37-49. PubMed ID: 9055206
    [Abstract] [Full Text] [Related]

  • 2. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
    Walz A, Dewald B, von Tscharner V, Baggiolini M.
    J Exp Med; 1989 Nov 01; 170(5):1745-50. PubMed ID: 2681518
    [Abstract] [Full Text] [Related]

  • 3. The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence.
    Malkowski MG, Lazar JB, Johnson PH, Edwards BF.
    J Mol Biol; 1997 Feb 21; 266(2):367-80. PubMed ID: 9047370
    [Abstract] [Full Text] [Related]

  • 4. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
    Reddigari SR, Kuna P, Miragliotta GF, Kornfeld D, Baeza ML, Castor CW, Kaplan AP.
    J Allergy Clin Immunol; 1992 Mar 21; 89(3):666-72. PubMed ID: 1372016
    [Abstract] [Full Text] [Related]

  • 5. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
    Car BD, Baggiolini M, Walz A.
    Biochem J; 1991 May 01; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
    [Abstract] [Full Text] [Related]

  • 6. Molecular cloning and characterisation of a neutrophil chemotactic protein from porcine platelets.
    Power CA, Proudfoot AE, Magnenat E, Bacon KB, Wells TN.
    Eur J Biochem; 1994 Apr 15; 221(2):713-9. PubMed ID: 7513641
    [Abstract] [Full Text] [Related]

  • 7. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein.
    Ehlert JE, Ludwig A, Grimm TA, Lindner B, Flad HD, Brandt E.
    Blood; 2000 Nov 01; 96(9):2965-72. PubMed ID: 11049972
    [Abstract] [Full Text] [Related]

  • 8. Regulation of glucose transporters by connective tissue activating peptide-III isoforms.
    Tai PK, Liao JF, Hossler PA, Castor CW, Carter-Su C.
    J Biol Chem; 1992 Sep 25; 267(27):19579-86. PubMed ID: 1527075
    [Abstract] [Full Text] [Related]

  • 9. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
    Leonard EJ, Yoshimura T, Rot A, Noer K, Walz A, Baggiolini M, Walz DA, Goetzl EJ, Castor CW.
    J Leukoc Biol; 1991 Mar 25; 49(3):258-65. PubMed ID: 1997632
    [Abstract] [Full Text] [Related]

  • 10. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
    Hoogewerf AJ, Leone JW, Reardon IM, Howe WJ, Asa D, Heinrikson RL, Ledbetter SR.
    J Biol Chem; 1995 Feb 17; 270(7):3268-77. PubMed ID: 7852412
    [Abstract] [Full Text] [Related]

  • 11. Activation of human basophils through the IL-8 receptor.
    Krieger M, Brunner T, Bischoff SC, von Tscharner V, Walz A, Moser B, Baggiolini M, Dahinden CA.
    J Immunol; 1992 Oct 15; 149(8):2662-7. PubMed ID: 1383321
    [Abstract] [Full Text] [Related]

  • 12. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
    Piccardoni P, Evangelista V, Piccoli A, de Gaetano G, Walz A, Cerletti C.
    Thromb Haemost; 1996 Nov 15; 76(5):780-5. PubMed ID: 8950790
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
    Härter L, Petersen F, Flad HD, Brandt E.
    J Immunol; 1994 Dec 15; 153(12):5698-708. PubMed ID: 7989767
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Novel C-terminally truncated isoforms of the CXC chemokine beta-thromboglobulin and their impact on neutrophil functions.
    Ehlert JE, Gerdes J, Flad HD, Brandt E.
    J Immunol; 1998 Nov 01; 161(9):4975-82. PubMed ID: 9794434
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structural requirements of platelet chemokines for neutrophil activation.
    Yan Z, Zhang J, Holt JC, Stewart GJ, Niewiarowski S, Poncz M.
    Blood; 1994 Oct 01; 84(7):2329-39. PubMed ID: 7919350
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution.
    Malkowski MG, Wu JY, Lazar JB, Johnson PH, Edwards BF.
    J Biol Chem; 1995 Mar 31; 270(13):7077-87. PubMed ID: 7706245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.